Second-line treatment of advanced non-small cell lung cancer non-oncogene addicted: new treatment algorithm in the era of novel immunotherapy.

CONCLUSION: The present paper discusses the old and new treatment opportunities, proposing a shared algorithm for second-line setting in advanced NSCLC.
PMID: 29992894 [PubMed - as supplied by publisher]

Source: Clinical Lung Cancer - July 11, 2018 Category: Cancer & Oncology Authors: Gridelli C, Ascierto PA, Grossi F, Baldini E, Favaretto A, Garassino MC, Morabito A, Migliorino MR, Rossi A, de Marinis F Tags: Curr Clin Pharmacol Source Type: research